Fate Therapeutics
FATE
#9091
Rank
HK$0.94 B
Marketcap
HK$8.18
Share price
-0.94%
Change (1 day)
-28.50%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: HK$0.94 Billion

As of January 2026 Fate Therapeutics has a market cap of HK$0.94 Billion. This makes Fate Therapeutics the world's 9091th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$0.94 B5.18%
2025HK$0.89 B-36.95%
2024HK$1.42 B-50.57%
2023HK$2.88 B-62.4%
2022HK$7.66 B-82.42%
2021HK$43.56 B-29.16%
2020HK$61.49 B432.81%
2019HK$11.54 B77.58%
2018HK$6.49 B158.66%
2017HK$2.51 B211.95%
2016HK$0.80 B7.39%
2015HK$0.75 B-6.53%
2014HK$0.80 B-19.35%
2013HK$0.99 B

End of Day market cap according to different sources

On Jan 10th, 2026 the market cap of Fate Therapeutics was reported to be:

HK$0.94 Billion
by Nasdaq info icon info icon
HK$0.94 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sarepta Therapeutics
SRPT
HK$19.46 B 1,961.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$451.04 B 47,677.96%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
HK$48.51 B 5,039.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
HK$84.99 B 8,902.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$105.52 B 11,078.21%๐Ÿ‡บ๐Ÿ‡ธ USA